BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J. Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact. World J Gastroenterol 2021; 27(17): 2039-2053 [PMID: 34007138 DOI: 10.3748/wjg.v27.i17.2039]
URL: https://www.wjgnet.com/1007-9327/full/v27/i17/2039.htm
Number Citing Articles
1
Alexander Kaserer, Julia Braun, Alexander Mair, Samira Akbas, Julian Rössler, Heike A. Bischoff-Ferrari, Matthias Turina, Pierre-Alain Clavien, Isabelle Opitz, Andreas Hülsmeier, Gergely Karsai, Greta Gasciauskaite, Gabriela H. Spahn, Martin Schläpfer, Donat R. Spahn. Ferric carboxymaltose with or without phosphate substitution in iron deficiency or iron deficiency anemia before elective surgery – The DeFICIT trialJournal of Clinical Anesthesia 2025; 101: 111727 doi: 10.1016/j.jclinane.2024.111727
2
Edyta Tulewicz-Marti, Paulina Szwarc, Martyna Więcek, Konrad Lewandowski, Tomasz Korcz, Malgorzata Cicha, G. Rydzewska. Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease—Results of a Prospective Single-Centre StudyJournal of Personalized Medicine 2023; 13(3): 458 doi: 10.3390/jpm13030458